about
Identification of Down's syndrome critical locus gene SIM2-s as a drug therapy target for solid tumorsBioinformatics approaches to cancer gene discovery.Differentiation of immortal cells inhibits telomerase activity.Characterization of human telomerase complex.Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regressionCell cycle-dependent modulation of telomerase activity in tumor cells.Antisense rel A in Cancer.Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.Strategies in Ebola virus disease (EVD) diagnostics at the point of care.Use of electroporation to study the cytotoxic effects of fluorodeoxyuridylate in intact cells.Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells.Antisense RNA to the putative tumor suppressor gene "deleted in colorectal cancer" transforms fibroblastsDNA-mediated gene transfer into epidermal cells using electroporationIn vivo expression of a nonselected gene transferred into murine hematopoietic stem cells by electroporationTranscriptional activation of the c-myc proto-oncogene in murine keratinocytes enhances the response to epidermal growth factorIntroduction of deoxyribonucleoside triphosphates into intact cells by electroporationA method to detect transfected chloramphenicol acetyltransferase gene expression in intact animalsEvaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1Enhancement by antisense oligonucleotides to NF-kappaB of the differentiation of HL-60 promyelocytic leukemia cells induced by vitamin D3
P50
Q24681268-774497CC-E580-48E3-8491-DA58506F0367Q33266746-7F888B49-DD52-40E7-AD83-EA2D23054243Q33670557-818F9AA4-E8BE-4D2E-B4BC-1177B8D10226Q36581467-40A58988-20FF-4E0E-A305-9C3516B39B1EQ36620956-0ED7F695-2B94-4646-ADE3-6379E6E13759Q37573521-F7F8C194-E427-4305-97DC-2200D8EF5B50Q37848158-7BB16D71-5C33-4901-8F99-6A3BF817098DQ38361683-5CF6785B-1F6A-428A-A2CE-CC3159F4F2A4Q38371191-277BCB1A-18B7-4EE6-9ABE-3D151AB7175CQ44450940-12CA166F-9299-440A-9D89-083A33CBB46BQ53497279-5792C283-F58A-41E5-984F-D1B45F25ECF1Q67510600-70B9A464-419E-44D8-9910-A2113E57D4F5Q68727339-81E827F6-2527-41E3-A4CC-A5A2592E5842Q68751117-C00E04BD-FBF0-4A9C-AFBF-EA9784EF28B4Q69083522-751E1743-FE9E-4348-85B6-27A707FA0146Q69741709-77FDA7E2-F21B-40CF-B243-148F2DABF0BAQ69814106-1400EAFB-4C60-48C3-A7FF-E29A8D0AF838Q70250268-A369928D-33DE-4554-8F70-76CB062EAB5BQ74497576-BBA63EA0-BB73-4D02-B072-781DA11A6A7B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
R Narayanan
@ast
R Narayanan
@en
R Narayanan
@es
R Narayanan
@nl
R Narayanan
@sl
type
label
R Narayanan
@ast
R Narayanan
@en
R Narayanan
@es
R Narayanan
@nl
R Narayanan
@sl
prefLabel
R Narayanan
@ast
R Narayanan
@en
R Narayanan
@es
R Narayanan
@nl
R Narayanan
@sl
P106
P1153
7202724194
P31
P496
0000-0001-9346-9083